The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma
出版年份 2020 全文链接
标题
The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma
作者
关键词
-
出版物
Lancet Haematology
Volume 8, Issue 1, Pages e80-e93
出版商
Elsevier BV
发表日期
2020-12-23
DOI
10.1016/s2352-3026(20)30365-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- High total metabolic tumor volume at baseline allows discrimination of survival even in patients aged 60 to 80 years responding to R-CHOP
- (2020) Laetitia Vercellino et al. BLOOD
- The Optimal Timing of Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma: An Individual Patient Data Meta-Analysis By the Petra Consortium
- (2020) Jakoba J Eertink et al. BLOOD
- Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma
- (2020) Connie L. Batlevi et al. EUROPEAN JOURNAL OF CANCER
- Prognostic Value of Interim FDG-PET in Diffuse Large Cell Lymphoma: Results from the CALGB 50303 Clinical Trial
- (2020) Heiko Schöder et al. BLOOD
- FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective study
- (2020) N. George Mikhaeel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYA
- (2020) Sarah C. Rutherford et al. Blood Advances
- Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA
- (2020) Steven Le Gouill et al. BLOOD
- Diagnostic and Prognostic Value of Using 18F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Peripheral T-Cell Lymphoma
- (2019) Yoshiaki Abe et al. CLINICAL NUCLEAR MEDICINE
- Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma
- (2019) Domenico Albano et al. ANNALS OF NUCLEAR MEDICINE
- Time to prepare for risk adaptation in lymphoma by standardising measurement of metabolic tumour burden
- (2019) Sally F. Barrington et al. JOURNAL OF NUCLEAR MEDICINE
- Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project
- (2019) Clément Bailly et al. HAEMATOLOGICA
- RESPONSE ORIENTED MAINTENANCE THERAPY IN ADVANCED FOLLICULAR LYMPHOMA. RESULTS OF THE INTERIM ANALYSIS OF THE FOLL12 TRIAL CONDUCTED BY THE FONDAZIONE ITALIANA LINFOMI.
- (2019) M. Federico et al. HEMATOLOGICAL ONCOLOGY
- Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial
- (2019) Christine Schmitz et al. EUROPEAN JOURNAL OF CANCER
- Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
- (2019) Viola Poeschel et al. LANCET
- Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma
- (2018) Luca Ceriani et al. BLOOD
- Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma
- (2018) Hajira Ilyas et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Feasibility of state of the art PET/CT systems performance harmonisation
- (2018) Andres Kaalep et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted-EPOCH-R: A paradigm shift in clinical decision making
- (2018) Christopher Melani et al. HAEMATOLOGICA
- Positron Emission Tomography–Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial
- (2018) Ulrich Dührsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Does PET Reconstruction Method Affect Deauville Scoring in Lymphoma Patients?
- (2018) Ronald Boellaard et al. JOURNAL OF NUCLEAR MEDICINE
- End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted-EPOCH-R: A paradigm shift in clinical decision making
- (2018) Christopher Melani et al. HAEMATOLOGICA
- Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis
- (2018) Coreline N. Burggraaff et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score
- (2018) Ho-Young Yhim et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
- (2018) David M. Kurtz et al. JOURNAL OF CLINICAL ONCOLOGY
- Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG
- (2018) Jessica L. Brady et al. BLOOD
- Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial
- (2018) Judith Trotman et al. LANCET ONCOLOGY
- Effect of PET/CT on the Management and Outcomes of Participants with Hodgkin and Aggressive Non-Hodgkin Lymphoma: A Multicenter Registry
- (2018) Ur Metser et al. RADIOLOGY
- FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
- (2017) Sally F. Barrington et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- RADIOTHERAPY TO BULKY DISEASE PET-NEGATIVE AFTER IMMUNOCHEMOTHERAPY CAN BE SPARED IN ELDERLY DLBCL PATIENTS: RESULTS OF a PLANNED INTERIM ANALYSIS OF THE FIRST 187 PATIENTS WITH BULKY DISEASE TREATED IN THE OPTIMAL > 60 STUDY OF THE DSHNHL
- (2017) M. Pfreundschuh et al. HEMATOLOGICAL ONCOLOGY
- Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma
- (2017) Luca Ceriani et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Predictive Value of PET Response Combined with Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma Patients
- (2017) Anne-Ségolène Cottereau et al. JOURNAL OF NUCLEAR MEDICINE
- Evaluating early interim fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography with the SUVmax-liver-based interpretation for predicting the outcome in diffuse large B-cell lymphoma
- (2017) Yang Fan et al. LEUKEMIA & LYMPHOMA
- Risk stratification of diffuse large B-cell lymphoma with interim PET-CT based on different cutoff Deauville scores
- (2017) Jihyun Kim et al. LEUKEMIA & LYMPHOMA
- The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study
- (2016) M. Alzahrani et al. ANNALS OF ONCOLOGY
- Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma
- (2016) A.-S. Cottereau et al. CLINICAL CANCER RESEARCH
- Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL
- (2016) N. George Mikhaeel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14
- (2016) Mark Hertzberg et al. HAEMATOLOGICA
- Baseline Metabolic Tumor Volume Predicts Outcome in High–Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies
- (2016) Michel Meignan et al. JOURNAL OF CLINICAL ONCOLOGY
- ATLAAS: an automatic decision tree-based learning algorithm for advanced image segmentation in positron emission tomography
- (2016) Beatrice Berthon et al. PHYSICS IN MEDICINE AND BIOLOGY
- Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14
- (2016) Mark Hertzberg et al. HAEMATOLOGICA
- Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma
- (2015) Tarec Christoffer El-Galaly et al. AMERICAN JOURNAL OF HEMATOLOGY
- Utility of interim and end-of-treatment PET/CT in peripheral T-cell lymphomas: A review of 124 patients
- (2015) Tarec Christoffer El-Galaly et al. AMERICAN JOURNAL OF HEMATOLOGY
- Delineating outcomes of patients with diffuse large b cell lymphoma using the national comprehensive cancer network-international prognostic index and positron emission tomography-defined remission status; a population-based analysis
- (2015) Mark J. Bishton et al. BRITISH JOURNAL OF HAEMATOLOGY
- Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404)
- (2015) Lode J. Swinnen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis
- (2015) Georg Kuhnert et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)
- (2015) Christoph Mamot et al. JOURNAL OF CLINICAL ONCOLOGY
- Utility of interim and end-of-treatment [18F]-fluorodeoxyglucose positron emission tomography–computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma
- (2015) Scott F. Huntington et al. LEUKEMIA & LYMPHOMA
- The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL)
- (2014) S. Luminari et al. ANNALS OF ONCOLOGY
- Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial
- (2014) Emilia Pardal et al. BRITISH JOURNAL OF HAEMATOLOGY
- FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
- (2014) Ronald Boellaard et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
- (2014) Sally F. Barrington et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective International Cohort Study Demonstrates Inability of Interim PET to Predict Treatment Failure in Diffuse Large B-Cell Lymphoma
- (2014) R. Carr et al. JOURNAL OF NUCLEAR MEDICINE
- Combined PET and Biopsy Evidence of Marrow Involvement Improves Prognostic Prediction in Diffuse Large B-Cell Lymphoma
- (2014) J. J. Cerci et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study
- (2014) Karen Juul Mylam et al. LEUKEMIA & LYMPHOMA
- Clinical impact of contrast-enhanced computed tomography combined with low-dose18F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management
- (2014) Julia Chalaye et al. LEUKEMIA & LYMPHOMA
- Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies
- (2014) Judith Trotman et al. Lancet Haematology
- The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi
- (2013) S. Luminari et al. ANNALS OF ONCOLOGY
- PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement
- (2013) A. B. Khan et al. BLOOD
- 18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma
- (2013) Carla Casulo et al. LEUKEMIA & LYMPHOMA
- Impact of [18F]Fluorodeoxyglucose Positron Emission Tomography Response Evaluation in Patients With High–Tumor Burden Follicular Lymphoma Treated With Immunochemotherapy: A Prospective Study From the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS
- (2012) Jehan Dupuis et al. JOURNAL OF CLINICAL ONCOLOGY
- SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma
- (2011) R.-O. Casasnovas et al. BLOOD
- Impact of Concordant and Discordant Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated With R-CHOP
- (2011) Laurie H. Sehn et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma
- (2010) Ludovic Le Dortz et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Improvement of Early 18F-FDG PET Interpretation in Diffuse Large B-Cell Lymphoma: Importance of the Reference Background
- (2010) E. Itti et al. JOURNAL OF NUCLEAR MEDICINE
- The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL)
- (2009) A. Noy et al. ANNALS OF ONCOLOGY
- Prognostic Value of Interim 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment at 4 Cycles of Chemotherapy
- (2009) E. Itti et al. JOURNAL OF NUCLEAR MEDICINE
- Report on the First International Workshop on interim-PET scan in lymphoma
- (2009) Michel Meignan et al. LEUKEMIA & LYMPHOMA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started